Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clonidine in Attention Deficit Hyperactivity Disorder (ADHD) Treatment (CAT)
NCT00031395Phase 3Completed
- Sponsor
- University of Cincinnati
- Start
- Sep 1999
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of clonidine in attention deficit hyperactivity disorder (ADHD), sponsored by University of Cincinnati. Started Sep 1999; status: completed.
02
Drugs
clonidine
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT00031395.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00031395.